BioAtla annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
BioAtla Capital Expenditures (CapEx) Growth & History (BCAB)
BioAtla's capital expenditures (capex) was $0 for fiscal 2024.
View full BioAtla company overviewBioAtla annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$98,000 | — |
| 2023 | 2023-12-31 | $98,000 | −$170,000 | −63.43% |
| 2022 | 2022-12-31 | $268,000 | −$656,000 | −71.00% |
| 2021 | 2021-12-31 | $924,000 | $334,000 | +56.61% |
| 2020 | 2020-12-31 | $590,000 | −$919,000 | −60.90% |
| 2019 | 2019-12-31 | $1.5M | — | — |
BioAtla quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | −$8,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$25,000 | — |
| Q2 2024 | 2024-06-30 | $0 | −$15,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$50,000 | — |
| Q4 2023 | 2023-12-31 | $8,000 | −$23,000 | −74.19% |
| Q3 2023 | 2023-09-30 | $25,000 | −$33,000 | −56.90% |
| Q2 2023 | 2023-06-30 | $15,000 | −$154,000 | −91.12% |
| Q1 2023 | 2023-03-31 | $50,000 | $40,000 | +400.00% |
| Q4 2022 | 2022-12-31 | $31,000 | −$58,000 | −65.17% |
| Q3 2022 | 2022-09-30 | $58,000 | −$41,000 | −41.41% |
| Q2 2022 | 2022-06-30 | $169,000 | −$66,000 | −28.09% |
| Q1 2022 | 2022-03-31 | $10,000 | −$491,000 | −98.00% |
| Q4 2021 | 2021-12-31 | $89,000 | −$306,000 | −77.47% |
| Q3 2021 | 2021-09-30 | $99,000 | −$10,000 | −9.17% |
| Q2 2021 | 2021-06-30 | $235,000 | $169,000 | +256.06% |
| Q1 2021 | 2021-03-31 | $501,000 | $481,000 | +2405.00% |
| Q4 2020 | 2020-12-31 | $395,000 | — | — |
| Q3 2020 | 2020-09-30 | $109,000 | — | — |
| Q2 2020 | 2020-06-30 | $66,000 | — | — |
| Q1 2020 | 2020-03-31 | $20,000 | — | — |
BioAtla capital expenditures (capex) trends
Over the last five fiscal years, BioAtla's capital expenditures (capex) decreased from $1.5M to $0, a change of −$1.5M. The latest reported quarter, Q1 2025, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioAtla source filings ↗